Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy

Annals of Ophthalmology

Volumn 39, Issue 3, 2007, Pages 205-208

  Celebiler Cavusoglu, A ^a   Bilgili, S ^a   Alaluf, A ^a   Dogan A ^a   Yilmaz F ^a   Aslanca, D ^a   Karaca, B ^a   Yuksel B ^a   Topaloglu, E ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; HUMAN; LASER COAGULATION; MALE; RETINOPATHY;

EID: 36948998565     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12009-007-0037-2     Document Type: Article

References (22)

1. De Vriese AS, Verbeuren TJ, Van de Voorde J, et al. Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-974.
2. Balasubramanyam M, Rema M, Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Curr Sci 2002;83:121506-121514.
3. Ferrara N, Houck KA, Jakeman LB, et al. The VEGF family of polypeptides. J Cell Biochem 1991;47:211-218.
4. Lenz T, Haak T, Malek J, et al. Vascular endothelial growth factor in diabetic nephropathy. Kidney Blood Press Res 2003;26:338-343.
5. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267:26031-26037.
6. Williams B.. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?. Vasc Med 1996;1:251-258.
7. Lip PL, Chatterjee S, Caine GJ, et al. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol 2004;88:1543-1546.
8. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1984;246:1309-1312.
9. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
10. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999;48:1899-1906.
11. Ferrara N.. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999;77:527-543.
12. Pe'er J, Folberg R, Itin A, et al. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:241-245.
13. Shinoda K, Ishida S, Kawashima S, et al. Comparison of levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol 1999;83:834-837.
14. Kozawa T, Sone H, Okuda Y, et al. Vascular endothelial growth factor levels in the aqueous and serum in diabetic retinopathy with or without neovascular glaucoma. Nippon Ganka Gakkai Zasshi 1998;102:731-738.
15. Boulton M, Foreman D, Williams G, et al. VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998;82:561-568.
16. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
17. Clermont AC, Aiello LP, Mori F, et al. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:433-446.
18. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996;103:1820-1828.
19. Tamarat R, Silvestre JS, Huijberts M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA. 2003;100:8555-8560.
20. Tanii M, Yonemitsu Y, Fujii T, et al. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the PDGF-BB/PKC axis, but not of impaired expression of angiogenic factors. Circ Res 2006;98:55-62.
21. Ito WD, Arras M, Winkler B, et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837.
22. Silvestre JS, Levy BI.. Molecular basis of angiopathy in diabetes mellitus. Circ Res 2006;98:4-6.